−58.5
Innate Pharma SA
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions EUR
FY21:
FY22:
−19.2
FY23:
−32.6
FY24:
−6.90
FY25:
−52.8
Change from FY21 to FY25
millions EUR
FY21:
−0.92
FY22:
1.88
FY23:
20.6
FY24:
9.20
FY25:
7.29
Change from FY21 to FY25
millions EUR
FY21:
26.8
FY22:
−1.83
FY23:
−1.97
FY24:
−6.01
FY25:
6.07
millions EUR
FY21:
−33.0
FY22:
−19.5
FY23:
−13.6
FY24:
−4.21
FY25:
−38.3
(positive)
Change from FY21 to FY25
millions EUR
FY21:
−59.4
FY22:
−19.7
FY23:
−32.9
FY24:
−7.29
FY25:
−52.9
All amounts in millions EUR